This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan
BOOK NOW
Menu
BOOK NOW

Jais Bjelke
Principal Scientist at Novo Nordisk, Norway
Speaker

Agenda Sessions

  • [Case Study] Engineering the Impossible: Breakthrough Strategies for the Oral Delivery of Complex Biologics

    , 09:00
    View Session

At this event

Prev
Next
Taichi Kuramochi
Head of Biologics Discovery
Chugai Pharmaceutical, Japan

See Jais at Antibody Engineering & Therapeutics Asia

BOOK NOW